Atlas FDA

ExAblate (Model 4000) System

FDA premarket approval P150038/S008 · decided 2018-10-24

Approval details

PMA number
P150038
Supplement
S008
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
ExAblate (Model 4000) System
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2018-07-23
Decision date
2018-10-24
Days to decision
93 days
Decision code
APPR
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Approval to include the 2-year and 3-year post-market study outcomes in the device labeling.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.